Purchases and Sales Made in Q2 2022 in Viracta Therapeutics, Inc. (VIRX)
This table provides information about the institutional ownership of Viracta Therapeutics, Inc. (VIRX) during Q2 2022. The information is specifically focused on institutions that hold shares of Viracta Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2022
Q2 2022
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-21.3K- 3.0% |
$39.9K - $107K
|
690K
$13.8K
|
|
|
Aug 04, 2022
Q2 2022
|
New York State Common Retirement Fund
|
SELL
|
- |
-21.6K- 98.13% |
$40.4K - $108K
|
411
$8.22
|
|
|
Aug 19, 2022
Q2 2022
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-28.9KClosed |
$54.1K - $145K
|
0
$0
|
|
|
Aug 11, 2022
Q2 2022
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-38.7KClosed |
$72.4K - $193K
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-64.7K- 99.53% |
$121K - $324K
|
303
$6.06
|
|
|
Aug 15, 2022
Q2 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-79.1KClosed |
$148K - $396K
|
0
$0
|
|
|
Jul 25, 2022
Q2 2022
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-87.8KClosed |
$164K - $439K
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-96.5K- 88.35% |
$180K - $482K
|
12.7K
$255
|
|
|
Aug 15, 2022
Q2 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-143KClosed |
$268K - $717K
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-245K- 87.97% |
$458K - $1.23M
|
33.5K
$671
|
|
|
Aug 12, 2022
Q2 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-278K- 57.73% |
$520K - $1.39M
|
204K
$4.07K
|
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-530K- 89.96% |
$990K - $2.65M
|
59.1K
$1.18K
|
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.77M- 76.55% |
$3.31M - $8.85M
|
542K
$10.8K
|